In addition, we compared the effects of different doses of BSHZF in PCOS-model rats and found that both CHM and CHH showed obvious therapeutic effects in ameliorating the clinical manifestations of PCOS and chronic inflammation. The gene discussed is RMRP; the disease is polycystic ovary syndrome.